Healthy Skepticism Library item: 10242
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
 Morgan SG, Mintzes B, Barer M.
 The economics of direct-to-consumer advertising of prescription-only drugs: Prescribed to improve consumer welfare? 
 Journal of Health Services Research and Policy 2003; 8:(4):237-244
 
Abstract:	
According to economic theory, one might expect that the informational content of direct-to-consumer advertising of prescription-only drugs would improve consumers’ welfare. However, contrasting the models of consumer and market behaviour underlying this theory with the realities of the prescription-only drug market reveals that this market is distinct in ways that render it unlikely that advertising will serve an unbiased and strictly informative function. A review of qualitative evidence regarding the informational content of drug advertising supports this conclusion. Direct-to-consumer prescription drug advertising concentrates on particular products, and features of those products, to the exclusion of others, and the information provided has frequently been found to be biased or misleading in regulatory and academic evaluations. Governments that have so far resisted direct-to-consumer advertising should invest in independent sources of evidence that could help consumers and professionals to better understand the risks and benefits of treating disease with alternative drug and non-drug therapies, rather than permitting direct-to-consumer prescription drug advertising.
Keywords:
Advertising/economics* 
Advertising/methods 
Advertising/standards 
Commerce/economics 
Commerce/ethics 
Drug Industry/economics* 
Drug Industry/ethics 
Drug Information Services/economics* 
Drug Information Services/standards 
Humans 
Mass Media 
Patient Education/economics 
Patient Participation* 
Persuasive Communication 
Physician-Patient Relations 
Prescriptions, Drug/economics* 
Social Welfare 
United States 
